| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/19/2014 | CN102432474B Preparation method of high-purity alkylammonium tetrafluoroborate for super capacitor |
| 03/19/2014 | CN101735113B Urea derivatives, preparation method and use thereof |
| 03/18/2014 | US8674089 Michael addition reaction product and active energy ray-curable composition |
| 03/18/2014 | US8673975 Indene derivatives as pharmaceutical agents |
| 03/18/2014 | US8673920 Inhibitors of the renal outer medullary potassium channel |
| 03/18/2014 | US8673904 Epoxide inhibitors of cysteine proteases |
| 03/18/2014 | CA2592154C N-hydroxyamide derivatives and use thereof |
| 03/13/2014 | WO2014039551A1 Preparation of dihydroxyethyl piperazine |
| 03/13/2014 | WO2014039412A1 Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists |
| 03/13/2014 | US20140073782 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives |
| 03/13/2014 | US20140073642 Quinazoline derivatives for the treatment of viral infections and further diseases |
| 03/13/2014 | US20140073627 Bradykinin b1 antagonists |
| 03/13/2014 | US20140073609 Compositions and Methods Including Cell Death Inducers and Procaspase Activation |
| 03/12/2014 | CN103635470A Chromene compound and curable composition |
| 03/12/2014 | CN103635468A Processes for the preparation of enamines |
| 03/12/2014 | CN103626722A Hypoglycemic compound of nitric oxide donor type, preparation method and purpose thereof |
| 03/12/2014 | CN103626721A Method for combined production of N-methyl morpholine and bis (2-dimethylaminoethyl) ether |
| 03/12/2014 | CN102256955B Process for preparation of piperazine derivatives |
| 03/11/2014 | US8669252 Prolylcarboxypeptidase inhibitors |
| 03/11/2014 | CA2631390C Phenoxy acetic acids as ppar delta activators |
| 03/11/2014 | CA2624383C Salts of modulators of ppar and methods of treating metabolic disorders |
| 03/06/2014 | WO2014036502A2 Tetracycline compounds |
| 03/06/2014 | WO2014033170A1 Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b |
| 03/06/2014 | US20140066432 Substituted Benzoazepines As Toll-Like Receptor Modulators |
| 03/06/2014 | US20140066369 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| 03/05/2014 | EP2703387A1 Cyclohexyl-substituted piperazine compounds |
| 03/05/2014 | CN103613567A Synthetic process for chlorcyclizine hydrochloride |
| 03/05/2014 | CN103613523A Thiocarbamic acid derivative and preparation method thereof |
| 03/05/2014 | CN103613510A Simple method for dehalogenating alpha-halogenated compounds |
| 03/05/2014 | CN103611467A Surfactant containing double spacer groups prepared by use of N,N'-bis(2-hydroxyethyl) piperazine and preparation method |
| 02/27/2014 | WO2014031226A1 The production of nitrogen compounds from a methane conversion process |
| 02/27/2014 | WO2014031162A1 Crystalline form of carbamoyl-cyclohexane derivatives |
| 02/27/2014 | WO2013186153A3 Amidophenoxypropanolamines |
| 02/27/2014 | US20140058097 Pharmaceutical composition for treating alzheimer's disease |
| 02/27/2014 | US20140057946 Estrogen receptor ligands and methods of use thereof |
| 02/27/2014 | US20140057913 Aurora kinase inhibitors and methods of making and using thereof |
| 02/27/2014 | US20140057910 Heterocyclic aspartyl protease inhibitors |
| 02/27/2014 | US20140057909 Novel Indole Derivative or Pharmaceutically Acceptable Salt Thereof, Preparation Method Thereof, and Pharmaceutical Composition for Preventing or Treating Metabolic Diseases Containing Same as Active Ingredient |
| 02/27/2014 | US20140057892 Prolyl hydroxylase inhibitors and methods of use |
| 02/27/2014 | US20140057877 Therapeutic polyamine compositions and their synthesis |
| 02/27/2014 | DE10322191B4 N-sulfonylierte Aminosäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung N-sulfonylated amino acid derivatives, processes for their preparation and their use |
| 02/26/2014 | EP2699543A1 Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission |
| 02/26/2014 | CN103601702A Preparation method of lomerizine hydrochloride |
| 02/26/2014 | CN103601701A Method for preparing levo-cloperastine fendizoic acid salt |
| 02/26/2014 | CN103601700A Preparation method of piperazine phosphate |
| 02/26/2014 | CN102482208B Ionic liquid containing allylsulfonate anion |
| 02/25/2014 | US8658691 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 02/25/2014 | US8658635 Benzpyrazol derivatives as inhibitors of PI3 kinases |
| 02/25/2014 | CA2510128C Composition, synthesis and therapeutic applications of polyamines |
| 02/20/2014 | WO2014028487A1 Amine-containing lipidoids and uses thereof |
| 02/20/2014 | WO2014026952A1 Dye composition comprising a cationic o-alkyl-substituted meta-phenylenediamine derivative |
| 02/20/2014 | WO2014008379A3 Diamine and meglumine salt forms of fatty acids |
| 02/20/2014 | US20140051858 Preparing method of solid carbamic acid derivatives |
| 02/20/2014 | US20140051857 Heterocyclic compounds and thrombopoietin receptor activators |
| 02/20/2014 | US20140051710 Crystalline form of carbamoyl-cyclohexane derivatives |
| 02/20/2014 | US20140051705 Morpholinoalkyl Fumarate Compounds, Pharmaceutical Compositions, and Methods of Use |
| 02/20/2014 | US20140051694 Aminooxazole Inhibitors of Cyclin Dependent Kinases |
| 02/20/2014 | US20140051686 3-Arylamino Pyridine Derivatives |
| 02/19/2014 | CN103596922A Amino lipids, their synthesis and uses thereof |
| 02/19/2014 | CN103596915A Partially fluorinated ketones and methods of making and using the same |
| 02/19/2014 | CN103588729A Synthetic method of 1-(biphenyl-4-yl)-2-methyl-2-morpholinopropan-1-one |
| 02/19/2014 | CN103588646A Method for making ethanolamine(s) and 1,2-ethyleneamine(s) from ethylene oxide and ammonia, and related method |
| 02/19/2014 | CN102574781B 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same |
| 02/18/2014 | US8653080 Methods for screening and compounds that protect against amyloid diseases |
| 02/13/2014 | WO2014023934A1 Immunomodulatory compounds |
| 02/13/2014 | WO2014023576A1 Process for the preparation of 2-cyanophenylboronic acid and esters thereof |
| 02/13/2014 | US20140046054 Process for preparing amines by homogeneously catalyzed alcohol amination in the presence of a complex catalyst comprising iridium and an amino acid |
| 02/13/2014 | US20140045851 Morpholines as selective inhibitors of cytochrome p450 2a13 |
| 02/13/2014 | US20140045842 Method for treating an inflammatory disease by administering a 1,2,3,4-tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent |
| 02/13/2014 | US20140045825 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture |
| 02/12/2014 | EP2694469A2 Method for preparing formamide compounds |
| 02/12/2014 | EP2693876A1 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds |
| 02/12/2014 | CN103570697A Method for preparing vilazodone and intermediate thereof |
| 02/12/2014 | CN103570645A Method for preparing N-(2,6-dimethyl phenyl)-2-(1-piperazine)acetamide |
| 02/12/2014 | CN103570553A Method for preparing N-substituted amine compound by virtue of catalytic alkylation |
| 02/12/2014 | CN102603676B Phosphodiesterase 4 inhibitor capable of avoiding vomiting reaction |
| 02/11/2014 | US8648110 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 02/11/2014 | US8648071 Hydrazonamide compounds that modulate Hsp90 activity |
| 02/11/2014 | US8648067 Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands |
| 02/11/2014 | US8647538 Photochromic compounds having at least two photochromic moieties |
| 02/11/2014 | CA2616160C Process of producing bepromoline |
| 02/11/2014 | CA2559187C Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
| 02/11/2014 | CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases |
| 02/06/2014 | WO2014022858A1 Enzyme-activating compounds and compositions |
| 02/06/2014 | WO2014020351A1 Receptor antagonists |
| 02/06/2014 | WO2014020350A1 Par2 receptor antagonists |
| 02/06/2014 | US20140039181 Method for producing n-substituted amine compounds through catalyzed alkylation |
| 02/06/2014 | US20140038980 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 02/06/2014 | US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/06/2014 | US20140038978 Heterocyclic compounds as ccr2b antagonists |
| 02/06/2014 | US20140038951 Pde10 inhibitors and related compositions and methods |
| 02/06/2014 | US20140038945 Piperazine pde4 inhibitors and uses thereof |
| 02/05/2014 | CN103554058A Preparation method of linezolid derivative |
| 02/05/2014 | CN103554057A 曲美他嗪衍生物及其制备方法 Trimetazidine derivatives and their preparation |
| 02/05/2014 | CN103553948A Ionic liquid containing ester-based functional group as well as preparation method and application thereof |
| 02/05/2014 | CN103553933A Method for preparing multifunctional conjugated compound |
| 02/04/2014 | US8642774 Compounds |
| 02/04/2014 | US8642761 Method for producing 3-amidinophenylalanine derivatives |
| 02/04/2014 | US8642594 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors |
| 02/04/2014 | US8641816 Vinyl ether compounds and methods of their preparation and use |